CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia.

[1]  L. Sharples,et al.  Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial. , 2016, JAMA.

[2]  Jane Nixon,et al.  Prognostic Value of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Suspected Coronary Heart Disease: Long-Term Follow-up of a Prospective, Diagnostic Accuracy Cohort Study , 2016, Annals of Internal Medicine.

[3]  R. Blankstein,et al.  Stress Perfusion Cardiac Magnetic Resonance Imaging Effectively Risk Stratifies Diabetic Patients With Suspected Myocardial Ischemia , 2016, Circulation. Cardiovascular imaging.

[4]  Sin-Ho Jung,et al.  Coronary Microvascular Dysfunction as a Mechanism of Angina in Severe AS: Prospective Adenosine-Stress CMR Study. , 2016, Journal of the American College of Cardiology.

[5]  E. Nagel,et al.  2015 Update on Acute Adverse Reactions to Gadolinium based Contrast Agents in Cardiovascular MR. Large Multi-National and Multi-Ethnical Population Experience With 37788 Patients From the EuroCMR Registry , 2015, Journal of Cardiovascular Magnetic Resonance.

[6]  S. Walker,et al.  Rationale and design of the Clinical Evaluation of Magnetic Resonance Imaging in Coronary heart disease 2 trial (CE-MARC 2): A prospective, multicenter, randomized trial of diagnostic strategies in suspected coronary heart disease , 2015, American heart journal.

[7]  E. Nagel,et al.  Diagnostic Accuracy of Stress Myocardial Perfusion Imaging Compared to Invasive Coronary Angiography With Fractional Flow Reserve Meta-Analysis , 2015, Circulation. Cardiovascular imaging.

[8]  G. Sun,et al.  Diagnostic accuracy of myocardial magnetic resonance perfusion to diagnose ischemic stenosis with fractional flow reserve as reference: systematic review and meta-analysis. , 2014, JACC. Cardiovascular imaging.

[9]  R. Blankstein,et al.  Risk stratification by regadenoson stress magnetic resonance imaging in patients with known or suspected coronary artery disease. , 2014, The American journal of cardiology.

[10]  P. Kolh,et al.  [2014 ESC/EACTS Guidelines on myocardial revascularization]. , 2014, Kardiologia polska.

[11]  M. Stuber,et al.  Compressed sensing single-breath-hold CMR for fast quantification of LV function, volumes, and mass. , 2014, JACC. Cardiovascular imaging.

[12]  D. Berman,et al.  Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. , 2014, JACC. Cardiovascular imaging.

[13]  A. W. M. van der Graaf,et al.  MRI and cardiac implantable electronic devices; current status and required safety conditions , 2014, Netherlands Heart Journal.

[14]  Jane Nixon,et al.  Comparison of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Women With Suspected Coronary Artery Disease From the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial , 2014, Circulation.

[15]  S. Petersen,et al.  Comparative cost-effectiveness analyses of cardiovascular magnetic resonance and coronary angiography combined with fractional flow reserve for the diagnosis of coronary artery disease , 2014, Journal of Cardiovascular Magnetic Resonance.

[16]  P. Kellman,et al.  Diagnostic accuracy of stress perfusion CMR in comparison with quantitative coronary angiography: fully quantitative, semiquantitative, and qualitative assessment. , 2014, JACC. Cardiovascular imaging.

[17]  G. Ronan,et al.  ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease , 2013, Journal of Nuclear Cardiology.

[18]  M. Friedrich,et al.  Indications, safety and image quality of cardiovascular magnetic resonance: experience in >5,000 North American patients. , 2013, International journal of cardiology.

[19]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[20]  Christopher M. Kramer,et al.  Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis. , 2013, Journal of the American College of Cardiology.

[21]  D. Berman,et al.  Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA , 2013, Journal of Nuclear Cardiology.

[22]  M. Pencina,et al.  Stress Cardiac Magnetic Resonance Imaging Provides Effective Cardiac Risk Reclassification in Patients With Known or Suspected Stable Coronary Artery Disease , 2013, Circulation.

[23]  Raymond Y Kwong,et al.  Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance , 2013, Journal of Cardiovascular Magnetic Resonance.

[24]  E. Nagel,et al.  Assessment of coronary artery stenosis severity and location: quantitative analysis of transmural perfusion gradients by high-resolution MRI versus FFR. , 2013, JACC. Cardiovascular imaging.

[25]  Scott D Flamm,et al.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing , 2013, Journal of Cardiovascular Magnetic Resonance.

[26]  S. Walker,et al.  Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study , 2013, Heart.

[27]  S. Plein,et al.  Reproducibility of first‐pass cardiovascular magnetic resonance myocardial perfusion , 2013, Journal of magnetic resonance imaging : JMRI.

[28]  J. Schwitter,et al.  MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. single-photon emission computed tomography for the detection of coronary artery disease: a comparative multicentre, multivendor trial. , 2013, European heart journal.

[29]  E. Nagel,et al.  European Cardiovascular Magnetic Resonance (EuroCMR) registry - multi national tesults from 57 centers in 15 countries , 2013, Journal of Cardiovascular Magnetic Resonance.

[30]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.

[31]  E. Nagel,et al.  Quantitative cardiovascular magnetic resonance perfusion imaging: inter-study reproducibility. , 2012, European heart journal cardiovascular Imaging.

[32]  E. Nagel,et al.  Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography. , 2012, Journal of the American College of Cardiology.

[33]  E. Nagel,et al.  Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease , 2012, Journal of Cardiovascular Magnetic Resonance.

[34]  V. Gudnason,et al.  Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. , 2012, JAMA.

[35]  J. Schwitter,et al.  Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial) , 2012, Journal of Cardiovascular Magnetic Resonance.

[36]  D. Bluemke,et al.  LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. , 2012, JACC. Cardiovascular imaging.

[37]  Shah Ebrahim,et al.  European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) , 2012, International Journal of Behavioral Medicine.

[38]  Massimo Lombardi,et al.  Cost evaluation of cardiovascular magnetic resonance versus coronary angiography for the diagnostic work-up of coronary artery disease: Application of the European Cardiovascular Magnetic Resonance registry data to the German, United Kingdom, Swiss, and United States health care systems , 2012, Journal of Cardiovascular Magnetic Resonance.

[39]  Peter Nordbeck,et al.  Minimizing Risk of Nephrogenic systemic fibrosis in Cardiovascular Magnetic Resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[40]  E. Nagel,et al.  Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis. , 2012, Journal of the American College of Cardiology.

[41]  R. Geuns,et al.  Diagnostic performance of stress myocardial perfusion imaging for coronary artery disease: a systematic review and meta-analysis , 2012, European Radiology.

[42]  S. Plein,et al.  Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial , 2012, The Lancet.

[43]  P. Kellman,et al.  A quantitative pixel-wise measurement of myocardial blood flow by contrast-enhanced first-pass CMR perfusion imaging: microsphere validation in dogs and feasibility study in humans. , 2012, JACC. Cardiovascular imaging.

[44]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[45]  J. Núñez,et al.  Prognostic implications of dipyridamole cardiac MR imaging: a prospective multicenter registry. , 2012, Radiology.

[46]  R. Hachamovitch,et al.  Incremental Prognostic Significance of Combined Cardiac Magnetic Resonance Imaging, Adenosine Stress Perfusion, Delayed Enhancement, and Left Ventricular Function Over Preimaging Information for the Prediction of Adverse Events , 2011, Circulation.

[47]  H. Katus,et al.  Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion. , 2010, Journal of the American College of Cardiology.

[48]  M. Hamon,et al.  Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease , 2010, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[49]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[50]  G. Pilz,et al.  Prognostic value of normal adenosine-stress cardiac magnetic resonance imaging. , 2008, The American journal of cardiology.

[51]  Guido Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[52]  S. Priori,et al.  Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[53]  R. Carlos,et al.  Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. , 2007, Journal of the American College of Cardiology.

[54]  J. Núñez,et al.  Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. , 2007, Journal of the American College of Cardiology.

[55]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[56]  Sebastian Kelle,et al.  Prognostic Value of Cardiac Magnetic Resonance Stress Tests: Adenosine Stress Perfusion and Dobutamine Stress Wall Motion Imaging , 2007, Circulation.

[57]  Guang-Zhong Yang,et al.  Interstudy reproducibility of quantitative perfusion cardiovascular magnetic resonance. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[58]  R. Balaban,et al.  Absolute myocardial perfusion in canines measured by using dual-bolus first-pass MR imaging. , 2004, Radiology.

[59]  Daniel C. Lee,et al.  Magnetic Resonance Versus Radionuclide Pharmacological Stress Perfusion Imaging for Flow-Limiting Stenoses of Varying Severity , 2004, Circulation.

[60]  James C Moon,et al.  Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. , 2004, American heart journal.

[61]  Shah Ebrahim,et al.  JOINT ESC GUIDELINES 2016 European Guidelines on cardiovascular disease prevention in clinical practice – Web Addenda , 2016 .

[62]  E. Fleck,et al.  Functional cardiac MR imaging with steady‐state free precession (SSFP) significantly improves endocardial border delineation without contrast agents , 2001, Journal of magnetic resonance imaging : JMRI.